Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Projected commercial pricing When Eli Lilly eventually brings retatrutide to market, likely in late 2027 or 2028, analysts project a list price of $1,000 to $1,500 per month based on comparable GLP-1 medications like Mounjaro and Ozempic
rapamycin inhibits mTOR-driven cell senescence
Depending on their sequence and composition, certain peptides may help prevent blood clots, boost the immune system, protect cells against damage, and reduce cholesterol, inflammation, and blood pressure
A less extreme example applies to most FMCGs
US$ 25.07
US$ 26.74
US$ 28.19
US$ 20.67
US$ 20.80
